FERGUSON STRATEGIES, LLC
Government affairs and public policy consulting firm.
Filings counts every document on the register, amendments included. Income is the fees reported to clients, counting the current version of each report once.
Income by year
Filings
| Filing | Client | Income | Expenses |
|---|---|---|---|
|
2nd Quarter - Termination 2nd Quarter 2016
|
INTEGRA LIFESCIENCES CORP. | $10,000 income | — expenses |
|
2nd Quarter - Termination 2nd Quarter 2016
|
ADVAXIS, INC. | $30,000 income | — expenses |
|
2nd Quarter - Termination 2nd Quarter 2016
|
ARALEZ PHARMACEUTICALS US INC (FORMERLY POZEN INC ) | $20,000 income | — expenses |
|
2nd Quarter - Termination 2nd Quarter 2016
|
NASDAQ (FORMERLY NASDAQ OMX GROUP) | $40,000 income | — expenses |
|
2nd Quarter - Termination 2nd Quarter 2016
|
PRUDENTIAL FINANCIAL INC. | $20,000 income | — expenses |
|
2nd Quarter - Termination 2nd Quarter 2016
|
CELGENE CORPORATION | $30,000 income | — expenses |
|
2nd Quarter - Termination 2nd Quarter 2016
|
THE MEDICINES COMPANY | $30,000 income | — expenses |
|
2nd Quarter - Termination 2nd Quarter 2016
|
PUBLIC SERVICE ENTERPRISE GROUP | $20,000 income | — expenses |
|
2nd Quarter - Termination 2nd Quarter 2016
|
EDGE THERAPEUTICS INC. | $20,000 income | — expenses |
|
2nd Quarter - Termination 2nd Quarter 2016
|
GENENTECH, INC. | $30,000 income | — expenses |
Clients
Everyone this filer has reported for, with the reports filed and the income they disclose.
| Client | Reports | Income |
|---|---|---|
| C.R. BARD INC. | 29 | $920,000 |
| FERGUSON STRATEGIES LLC | 29 | — |
| PUBLIC SERVICE ENTERPRISE GROUP | 22 | $440,000 |
| THE MEDICINES COMPANY | 20 | $570,000 |
| CELGENE CORPORATION | 17 | $560,000 |
| GENENTECH, INC. | 14 | $340,000 |
| NOVARTIS | 14 | $260,000 |
| PRUDENTIAL FINANCIAL INC. | 13 | $260,000 |
| ELI LILLY AND COMPANY | 12 | $360,000 |
| EDGE THERAPEUTICS INC. | 12 | $60,000 |
| NASDAQ (FORMERLY NASDAQ OMX GROUP) | 10 | $310,000 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 9 | $260,000 |
| ENDO PHARMACEUTICALS INC. | 7 | $190,000 |
| ARALEZ PHARMACEUTICALS US INC (FORMERLY POZEN INC ) | 6 | $170,000 |
| DENDREON CORP. | 5 | $170,000 |
| VERIZON SERVICES CORP. | 5 | $45,000 |
| LIGHTENING ENERGY | 5 | — |
| AUXILIUM PHARMACEUTICALS, INC. | 4 | $140,000 |
| ADVAXIS, INC. | 4 | $120,000 |
| US HEALTHCARE SUPPLY, LLC | 4 | $120,000 |
| MERCK & CO., INC. | 4 | $100,000 |
| BODE TECHNOLOGY GROUP, INC. | 4 | $80,000 |
| TRIAX PHARMACEUTICALS LLC | 4 | $40,000 |
| AKRIMAX PHARMACEUTICALS, LLC | 4 | $10,000 |
| CARE CONCEPTS LOUISIANA, INC. | 3 | $60,000 |
| HOFFMANN-LA ROCHE INC. | 3 | $50,000 |
| INTEGRA LIFESCIENCES CORP. | 1 | $10,000 |
Lobbyists
Everyone named on this filer's reports, with the government post they most recently disclosed here.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK EPLEY | — |
| ADAM HIGGINS | Legislative Assistant, Rep. Mike Ferguson. |
| CHRIS JONES | Chief of Staff, Rep. Mike Ferguson; Deputy Chief of Staff, Rep. David McIntosh; Communications Director, House Government Reform and Oversight Subcommittee; and Press Secretary, Rep. John Myers. |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
From reports filed under the Lobbying Disclosure Act. A firm reports income from each client; an organisation lobbying for itself reports its own expenses instead. Each figure links to the filing it comes from.